In this week’s edition of InnovationRx, we look at Trump's massive health agency layoffs, Palantir’s trade secret lawsuit, ...

Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative ...

Life sciences companies have decided to chop hundreds of Bay Area jobs in a fresh wave of layoffs that hint at ongoing ...

We recently published a list of 7 Most Profitable Biotech Stocks To Buy Right Now. In this article, we are going to take a ...

It was a busy week in the biotech sector, marked by significant regulatory and pipeline updates. Among these, shares of ...

Discover March 2025’s top biotech deals, featuring major collaborations in small molecules, bispecific antibodies and protein ...

British biotech CellCentric is settling into a new office in Boston, part of the company’s expansion into the U.S. as ...

Novavax ticked up, but remained deep in the red for the year to date. The Federal Trade Commission's lawsuit against three large pharmacy-benefit managers over insulin prices -- Cigna's Express ...

While Pliant Therapeutics and Acelyrin recently blocked ever-eager acquirer Concentra Biosciences with “poison pill” defenses ...

President Trump is expected to unveil his massive tariff plan today, what he has called “Liberation Day.” He recently said ...

Moleculin Biotech has begun dosing subjects in a Phase III trial of Annamycin with Cytarabine for treating acute myeloid ...

Insiders have lately been showing their love for these three biotech stocks, two tech stocks, and a utility stock with huge ...